Ocular Changes With Alpha-2 Receptor Agonist.

计划入组 150 人 · 首次发布于 2023 年 1 月 4 日

Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

计划入组 20 人 · 首次发布于 2024 年 6 月 5 日

Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

计划入组 100 人 · 首次发布于 2023 年 5 月 6 日

orexin 2 receptor agonist (narcolepsy)

Dual Orexin OX1/OX2 Receptor Agonists (Orexia)

Orexin 2R NAM program (Addex)

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

MEREO BIOPHARMA 2 LIMITED

United Kingdom

Eisai Presents Phase Ib Data on Novel Orexin Agonist E2086 for Narcolepsy at World Sleep 2025

Eisai's E2086 Receives Orphan Drug Designation in Japan for Narcolepsy Treatment

Alkermes Presents Positive Phase 1b Data for ALKS 2680 in Narcolepsy Type 2 and Idiopathic Hypersomnia